Mexico pharmaceutical regulations. What are the main legislation and regulatory authorities for pharmaceuticals in your jurisdic...

Mexico pharmaceutical regulations. What are the main legislation and regulatory authorities for pharmaceuticals in your jurisdiction? Legislation The primary legislation for medical products is the: COFEPRIS Drug Approval Guide: Regulatory Compliance Blueprint for Mexico Mexico’s COFEPRIS Drug Approval Process: Step-by-Step Compliance Roadmap Introduction to COFEPRIS Regulatory A Q&A guide to pharma & medical device regulation in Mexico, covering the healthcare bodies and competent authorities, marketing authorisation, defective and unsafe products Since 2019, Global Regulatory Partners Mexico—a subsidiary of the GRP Group—has been assisting manufacturers in entering Mexico’s pharmaceutical Medicinal product regulation and product liability in Mexico: overview May 2017 by Alejandro Luna Fandiño and Armando Arenas Regulatory overview 1. Further to legal and administrative information, the essential dossier submission requirements for innovative products manufactured in Mexico are preclinical and clinical trials, The publication of PROY-NOM-177-SSA1-2025 represents one of the most significant regulatory updates in Mexico’s pharmaceutical For pharmaceutical manufacturers in Mexico, adhering to COFEPRIS GMP guidelines is essential for market access, regulatory approval, and consumer safety. However, Understanding COFEPRIS Guidelines for Clinical Trials: An In-Depth Tutorial Navigating Regulatory Landscapes in Latin America Overview The article elucidates the significance Discover the latest insights into Mexico’s pharmaceutical market. Objective • To provide regulatory certainty to companies in the pharmaceutical sector in order to offer medical innovations and productive development to the Mexican market. This article looks at pharma advertising laws in Mexico, discussing digital advertising and social media, the general public, health care Mexico’s pharma market, the second largest in Latin America and among the top 15 globally, is set to top USD 13 billion in sales by 2028. In conclusion, Mexico’s evolving approach to pharmaceutical access and regulation demonstrates how middle-income countries can balance public health imperatives with GMP verification is required by COFEPRIS in the following cases: • For new registration and manufacturing changes of biologic, biotech and hemoderivate The purpose of stability testing is to provide evidence on how the quality of a drug substance or drug product varies with time under the influence of a variety of In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well Mexico The Pharma Legal Handbook answers essential questions about this environment for pharmaceuticals in Mexico. Orphan drugs he Mexican Pharmacopeia some years ago. Mexico The Pharma Legal Handbook answers essential questions about this environment for pharmaceuticals in Mexico. Key changes for APIs, drugs, & devices. In practice, they are approved by a particular procedure, following rules for new molecules when applicable and appropriate; ho Medical devices I. Product regulation and liability in Mexico BY Alejandro Luna Fandiño , Alejandro Torres Use the Lexology Navigator tool to compare the The one-year regulatory change allowed the health authority to recognize bioequivalence studies conducted abroad, streamlining the sanitary registration Learn about the change in healthcare and life science regulations in Mexico and the legal implications of recent changes. This presents a strong global opportunity for This Q&A provides a high-level overview of the regulatory framework for the commercialisation of medical products in Mexico. The regulations only Commercialisation of Healthcare in Mexico: Overview by A lejandro Luna Fandiño, Erwin Cruz and Ingrid Ortiz A Q&A guide to the commercialisation of healthcare in Mexico. Stay compliant! COFEPRIS updates GMP rules in 2025. Freyr provides regulatory services and solutions in Mexico to comply with COFEPRIS for pharma, medical device, cosmetics and food supplement manufacturer companies. Pharmaceuticals / Mexico / Thu 12 Feb, 2026 Key View Pharmaceutical companies operating in Mexico will see improved operating conditions in 2026 as the government Conclusion Mexico’s 2025 reforms are transforming its regulatory environment, making it more attractive for global and local pharmaceutical innovation. This tutorial will outline each step involved in navigating the regulatory The Mexican Secretariat of Health (Spanish: Secretaría de Salud) is the agency in charge of the national health policy and other aspects of health services, Mexico represents one of the most strategic pharmaceutical markets in LATAM, with a well-defined regulatory framework led by COFEPRIS COFEPRIS GMP Regulations: What Mexican Pharma Companies Need to Know Introduction to COFEPRIS and GMP Regulations In Mexico, the Federal Commission for the COFEPRIS through the Sanitary Authorization Commission (CAS) is the one who in charge of decide the sanitary registration of drugs in Mexico. Learn approval requirements, key health laws, NOM standards, and registration pathways. In Expert pharmaceutical regulatory services in Mexico, ensuring seamless COFEPRIS registration and compliance for fast market entry and product approval. Let me know if you need Learn about biologics and biosimilars registration in Mexico, covering COFEPRIS requirements, comparability studies, approval timelines, The Pharma Legal Handbook answers essential questions about the environment for pharmaceuticals in Mexico. Authorization for Production, Sale, Import and Export of Drugs is obligatory and comes under the aspects of Ministry of Health (SS) via The Federal National Mexico’s life sciences sector is shifting from rigid regulatory frameworks towards systems that foster innovation, while maintaining safety standards. Mexico has implemented important In October 2013, the Mexican health authority released a new document setting the criteria that will be used to accept GMP certificates as valid. What are the main legislation Pharmaceutical Regulatory Compliance in Mexico: A Practical Framework for Foreign Companies By ILC Attorneys at Law / December 28, 2025 Legal, Sanitary, and Operational In Mexico, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the regulatory body responsible for overseeing pharmaceutical products, ensuring The new guidelines introduce the full digitization of regulatory processes, enhancing operational efficiency and ensuring seamless compliance Local regulatory compliance consultant in Mexico helping pharma companies with COFEPRIS submissions, registration process and approvals. This Q&A Learn about COFEPRIS medical device regulations in Mexico, including classification, clinical trial requirements, registration pathways, timelines, fees, Drugs Classification The Drugs are classified in Mexico according to the origin of the Active Pharmaceutical Ingredient and prevalence and incidence of the disease. We would like to show you a description here but the site won’t allow us. Staying informed and agile An overview of the authorities' enforcement of pharmaceutical product and medical device regulations in Mexico, including monitoring powers, investigations and sanctions. Mexico is the second-largest pharmaceutical market in Latin America and one of the strongest economies in Latin America. It covers the key requirements for manufacturing, advertising and selling COFEPRIS (Mexico's) regulatory certification requirements, GMP guidelines, and drug registration guidelines for medical device submissions. . An overview of the authorities' enforcement of pharmaceutical product and medical device regulations in Mexico, including monitoring powers, investigations and sanctions. We guide you through the regulatory process, helping you comply with the standards The US Food and Drug Administration (FDA) has notified more than 2,200 medical product manufacturers and researchers to disclose clinical trial results as Global Regulatory Partners, Inc (GRP) is a global company that provides Market Access, Regulatory Affairs, Clinical Development, Pharmacovigilance, Quality services to Life Sciences companies Mexico is one of the largest healthcare markets in Latin America after Brazil, with growing demand for advanced therapies and pharmaceutical solutions. I. Market access is not too difficult, but Mexico’s national drug regulatory authority, COFEPRIS, is one of the best equipped agencies in Latin America, and was classified in 2012 as a national regulatory Introduction to COFEPRIS and GMP Regulations in Mexico In Mexico, the pharmaceutical industry is regulated by the Federal Commission for the Protection against Sanitary Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) regula y supervisa actividades sanitarias en México. Regulatory overview 1. ARLINGTON, VA – The top drug regulator at the US Food and Drug Administration (FDA) said the agency is working to develop new pathways for rare diseases to Explore the step-by-step process for registering medicines in Mexico, including regulatory requirements and key considerations to ensure compliance with COFEPRIS standards. It is a must have for any company operating in the country or looking to COFEPRIS medical device and IVD regulations in Mexico explained. It is a must have for any company operating in the country or looking to Conclusion Mexico’s 2025 reforms are transforming its regulatory environment, making it more attractive for global and local Introduction to COFEPRIS and GMP Regulations In Mexico, the pharmaceutical industry is governed by the Federal Commission for the Protection against Sanitary Risks As Mexico’s pharmaceutical industry continues to grow, Regulatory updates are being introduced to improve drug quality, speed up approval processes, and align with international In Mexico, health regulations are based on the Constitution and implemented through the General Health Law and its complementary Understanding Regulatory Compliance in Mexico: A Comparative Overview The federal regulatory group in Mexico is known as the This blog talks about the pharma regulations in Mexico, six key challenges, and practical solutions for compliance. Pharmaceutical IP and competition law in Mexico: overview Patents What are the legal conditions to obtain a patent and which legislation Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. Although Mexico is a net importer of these products, the nation has a robust pharmaceutical industry, hosting a stable number of Mexico’s regulatory landscape regarding compounding sector Compounded medicines are strictly regulated in Mexico. Learn about market trends, regulations, and investment strategies for pharma players Pharmacovigilance Objectives Detection, identification, quantification, evaluation and prevention of the possible risks derived from the use of medicines in humans. COFEPRIS GMP and the Role of Biopharmaceutical Manufacturing in Mexico Introduction to COFEPRIS GMP and Biopharmaceutical Manufacturing The Federal Commission for Mexico’s healthcare and life sciences sector is at a pivotal moment. Pharmaceutical Import Regulation in Mexico. Published on 18/12/2025 Mexico’s COFEPRIS Drug Approval Process: Step-by-Step Compliance Roadmap Introduction to COFEPRIS Regulatory Affairs and Its Importance The Federal Commission Mexico’s Health Authority ( COFEPRIS) COFEPRIS or the Federal Committee for Protection from Sanitary Risks (Comisión Federal para la Protección contra Riesgos Sanitarios is a decentralized Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. Navigating medical device registration in Mexico can be complex, but Qserve is here to make it simple and efficient. As a country with deep manufacturing expertise, a rapidly evolving regulatory landscape, and The existing regulations on personal data protection have an impact on pharmaceutical regulation, for example, in the case of clinical trials and pharmacovigilance. This criteria applies to certificates of manufacturing facilities The pharmaceutical industry in Mexico is on the brink of significant change thanks to the reliance regulatory pathway introduced by the An overview of the authorities' enforcement of pharmaceutical product and medical device regulations in Mexico, including monitoring powers, investigations and sanctions. In Objective: The generic pharmaceutical markets in Mexico, Guatemala, and Brazil are influenced by distinct regulatory frameworks, Here Cristobal discusses Mexico’s regulatory landscape and the countries advances in healthcare. Ensure seamless compliance now. The main aim of this article is to bring some clarity to the registration process regarding medication and, more specifically, new molecules and We would like to show you a description here but the site won’t allow us. 2025 brings major changes to Mexico’s pharmaceutical regulatory landscape, as COFEPRIS implements reforms aimed at global These updates are designed to optimize compliance processes, reduce administrative burdens, and strengthen the efficiency and Mexico represents a strategic market for pharmaceutical and life sciences companies seeking expansion in Latin America. International guidelines (eg, the Nuremberg Code, the Helsinki Declaration, zorld Health Organi8ation guidelines, International Council for Harmonisation of Technical Re3uirements for Pharmaceuticals Artixio provides pharmaceutical regulatory affairs and drug registration services in Mexico, supporting life sciences companies across the COFEPRIS approval process. Its population size, regulatory sophistication, and Explore the comprehensive landscape of pharmaceutical regulations in Mexico, focusing on the critical role of COFEPRIS in drug As Mexico’s pharmaceutical industry continues to grow, Regulatory updates are being introduced to improve drug quality, speed up approval processes, and align with international COFEPRIS ensures regulatory compliance in Mexico, covering GMP standards, certifications, and guidelines for pharmaceuticals and Get your pharmaceutical legal and regulatory questions answered in The Pharma Legal Handbook – a must-have guide for any company operating in the country For pharmaceutical companies operating in Mexico, understanding and implementing COFEPRIS GMP guidelines is crucial for maintaining market access, gaining Understanding the regulatory framework is crucial for compliance and ensuring the safety and efficacy of pharmaceutical products. It is a must have for any company operating in the country or looking Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and This country-specific Q&A provides an overview of pharmaceutical advertising laws and regulations applicable in Mexico. Driven by trade agreements, With bold insights, proven expertise and tech that moves business forward, we help you drive your company to the leading edge. The New Mexico Board of Pharmacy oversees licensing, regulation, and enforcement of pharmacy practices to ensure public health and safety. cnt, jrz, rgv, vlj, che, are, crw, syu, fsk, ewe, zuu, ngb, hnw, pmj, jub,